The goal is not to choke out innovation by banning GenAI in the workplace; it is to make it as safe as possible.

Discover MannKind's evolving pipeline, strategic acquisitions, and upcoming Afrezza pediatric launch from the 2025 Wells Fargo Healthcare Conference.